Search results
23andMe is low on cash and its stock is worth pennies. The CEO wants another chance
CNN Business via Yahoo Finance· 3 months agoJust three years ago, DNA testing company 23andMe was the golden child of Wall Street and Silicon...
23andMe CEO Says Company Is Doing Fine Despite Losing 93% of Stock Value
Futurism via Yahoo News· 2 months agoThe consumer genome sequencing company 23andMe is a sinking ship – and their CEO is playing the...
23andMe Holding Co. (NASDAQ:ME) Q3 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months ago23andMe Holding Co. (NASDAQ:ME) Q3 2024 Earnings Call Transcript February 7, 2024 23andMe Holding...
Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe
Motley Fool· 8 months agoRecursion Pharmaceuticals (NASDAQ: RXRX) and 23andMe (NASDAQ: ME) are both popular biotech stocks...
23andMe's share price keeps on falling in the wake of hacks and losses
Business Insider via Yahoo Finance· 3 months ago23andMe CEO Anne Wojcicki.Steve Jennings/Getty Images/TechCrunch 23andMe stock is down over 95% from...
23andMe's lesson to tech elites: The days of sloppy security are over
Salon via Yahoo News· 3 months ago23andMe Smith Collection/Gado/Getty Images This isn’t the first time at-home genetic testing company...
23andMe’s Fall From $6 Billion to Nearly $0
The Wall Street Journal· 3 months agoTECHNOLOGY Five years ago, 23andMe was one of the hottest startups in the world. Millions of people were spitting into its test tubes to learn about...
Is 23andMe Stock a Smart Buy Right Now?
Motley Fool via Yahoo Finance· 2 months agoGenetic-testing company 23andMe (NASDAQ: ME) is a household name, but does that make it a smart investment? After all, if the tangible health benefits of...
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
Motley Fool via Yahoo Finance· 1 month agoIf you're an individual investor who wants to invest like a billionaire fund manager, I've got good...
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics
Motley Fool· 11 months agoMost biotechs don't have a diversified business model. Both 23andMe and Fulgent provide genetic...
